Oblong (OBLG) 10-Q 14 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 13, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-35376
Entity Registrant Name	OBLONG, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0312442
Entity Address, Address Line One	25587 Conifer Road
Entity Address, Address Line Two	Suite 105-231
Entity Address, City or Town	Conifer
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80433
City Area Code	303
Local Phone Number	640-3838
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	OBLG
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		14,947,922
Entity Central Index Key	0000746210
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 6,766	$ 3,085
Accounts receivable, net	157	415
Inventory, net	324	723
Prepaid expenses and other current assets	330	649
Total current assets	7,577	4,872
Property and equipment, net	0	3
Intangibles, net	345	604
Operating lease - right of use asset, net	41	142
Other assets	16	40
Total assets	7,979	5,661
Current liabilities:
Accounts payable	106	184
Accrued expenses and other current liabilities	974	1,074
Current portion of deferred revenue	157	436
Current portion of operating lease liabilities	43	219
Total current liabilities	1,280	1,913
Long-term liabilities:
Operating lease liabilities, net of current portion	0	17
Deferred revenue, net of current portion	38	114
Total liabilities	1,318	2,044
Commitments and contingencies (see Note 11)
Stockholders’ equity:
Preferred stock Series F, convertible; $.0001 par value; $5,263,100 stated value; 42,000 shares authorized, 5,146 and zero shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	0	0
Common stock, $.0001 par value; 150,000,000 shares authorized; 4,294,455 shares issued and 4,286,902 outstanding at September 30, 2023 and 2,070,861 shares issued and 2,063,308 shares outstanding at December 31, 2022	0	0
Treasury stock, 7,553 shares of common stock	(181)	(181)
Additional paid-in capital	233,852	227,645
Accumulated deficit	(227,010)	(223,847)
Total stockholders' equity	6,661	3,617
Total liabilities and stockholders’ equity	$ 7,979	$ 5,661

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 5,263,100	$ 5,263,100
Preferred stock, convertible, shares authorized (in shares)	42,000	42,000
Preferred stock, shares issued (in shares)	5,146	0
Preferred stock, shares outstanding (in shares)	5,146	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	4,294,455	2,070,861
Common stock, shares outstanding (in shares)	4,286,902	2,063,308
Treasury stock, shares (in shares)	7,553	7,553

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 872	$ 1,185	$ 2,866	$ 4,050
Cost of revenue (exclusive of depreciation and amortization and casualty loss)	648	841	2,244	2,800
Gross profit	224	344	622	1,250
Operating expenses (gains):
Research and development	5	232	16	1,634
Sales and marketing	81	282	241	1,161
General and administrative	977	1,229	3,723	4,104
Impairment charges	0	5,169	2	12,715
Casualty loss (gain), net of insurance proceeds	0	0	(400)	533
Depreciation and amortization	86	592	259	1,818
Total operating expenses	1,149	7,504	3,841	21,965
Loss from operations	(925)	(7,160)	(3,219)	(20,715)
Interest and other expense, net	15	3	26	9
Other income	(45)	(8)	(120)	(8)
Interest and other (income) expense, net	(30)	(5)	(94)	1
Loss before income taxes	(895)	(7,155)	(3,125)	(20,716)
Income tax (benefit) expense	0	(3)	38	8
Net loss	(895)	(7,152)	(3,163)	(20,724)
Preferred stock dividends	133	0	282	0
Induced conversion of warrants	0	0	751	0
Warrant modification	0	0	25	0
Net loss attributable to common stockholders	$ (1,028)	$ (7,152)	$ (4,221)	$ (20,724)
Net loss attributable to common stockholders per share:
Basic net loss per share (in dollars per share)	$ (0.30)	$ (3.46)	$ (1.58)	$ (10.04)
Diluted net loss per share (in dollars per share)	$ (0.30)	$ (3.46)	$ (1.58)	$ (10.04)
Weighted-average number of shares of common stock:
Basic (in shares)	3,463	2,065	2,676	2,065
Diluted (in shares)	3,463	2,065	2,676	2,065

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)	Total	Series F Preferred Stock	Preferred Stock Series F Preferred Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit
Common stock, beginning balance (in shares) at Dec. 31, 2021				2,070,861
Treasury stock, beginning balance (in shares) at Dec. 31, 2021					7,553
Beginning balance at Dec. 31, 2021	$ 25,497,000			$ 0	$ (181,000)	$ 227,584,000	$ (201,906,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,539,000)						(4,539,000)
Stock-based compensation	52,000					52,000
Forfeiture of unvested stock options	(84,000)					(84,000)
Common stock, ending balance (in shares) at Mar. 31, 2022				2,070,861
Treasury stock, ending balance (in shares) at Mar. 31, 2022					7,553
Ending balance at Mar. 31, 2022	20,926,000			$ 0	$ (181,000)	227,552,000	(206,445,000)
Common stock, beginning balance (in shares) at Dec. 31, 2021				2,070,861
Treasury stock, beginning balance (in shares) at Dec. 31, 2021					7,553
Beginning balance at Dec. 31, 2021	25,497,000			$ 0	$ (181,000)	227,584,000	(201,906,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(20,724,000)
Series F Preferred Stock dividends	0
Treasury stock, ending balance (in shares) at Sep. 30, 2022					7,553
Ending balance at Sep. 30, 2022	4,803,000			$ 0	$ (181,000)	227,614,000	(222,630,000)
Common stock, beginning balance (in shares) at Mar. 31, 2022				2,070,861
Treasury stock, beginning balance (in shares) at Mar. 31, 2022					7,553
Beginning balance at Mar. 31, 2022	20,926,000			$ 0	$ (181,000)	227,552,000	(206,445,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,033,000)						(9,033,000)
Stock-based compensation	31,000					31,000
Common stock, ending balance (in shares) at Jun. 30, 2022				2,070,861
Treasury stock, ending balance (in shares) at Jun. 30, 2022					7,553
Ending balance at Jun. 30, 2022	11,924,000			$ 0	$ (181,000)	227,583,000	(215,478,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,152,000)						(7,152,000)
Stock-based compensation	31,000					31,000
Treasury stock, ending balance (in shares) at Sep. 30, 2022					7,553
Ending balance at Sep. 30, 2022	$ 4,803,000			$ 0	$ (181,000)	227,614,000	(222,630,000)
Preferred stock, beginning balance (in shares) at Dec. 31, 2022	0		0
Common stock, beginning balance (in shares) at Dec. 31, 2022	2,070,861			2,070,861
Treasury stock, beginning balance (in shares) at Dec. 31, 2022	7,553				7,553
Beginning balance at Dec. 31, 2022	$ 3,617,000		$ 0	$ 0	$ (181,000)	227,645,000	(223,847,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,219,000)						(1,219,000)
Stock-based compensation	31,000					31,000
Proceeds from private placement, net of fees and amounts held in escrow (in shares)			6,550
Proceeds from private placement, net of fees and amounts held in escrow	1,473,000					1,473,000
Preferred stock, ending balance (in shares) at Mar. 31, 2023			6,550
Common stock, ending balance (in shares) at Mar. 31, 2023				2,070,861
Treasury stock, ending balance (in shares) at Mar. 31, 2023					7,553
Ending balance at Mar. 31, 2023	$ 3,902,000		$ 0	$ 0	$ (181,000)	229,149,000	(225,066,000)
Preferred stock, beginning balance (in shares) at Dec. 31, 2022	0		0
Common stock, beginning balance (in shares) at Dec. 31, 2022	2,070,861			2,070,861
Treasury stock, beginning balance (in shares) at Dec. 31, 2022	7,553				7,553
Beginning balance at Dec. 31, 2022	$ 3,617,000		$ 0	$ 0	$ (181,000)	227,645,000	(223,847,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,163,000)
Stock-based compensation (in shares)				179,535
Common stock exchanged for pre-funded warrants (in shares)				(406,776)
Conversions of Series F Preferred Stock (in shares)				2,111,337
Series F Preferred Stock dividends	$ (282,000)
Preferred stock, ending balance (in shares) at Sep. 30, 2023	5,146	5,146	5,146
Common stock, ending balance (in shares) at Sep. 30, 2023	4,294,455			4,294,455
Treasury stock, ending balance (in shares) at Sep. 30, 2023	7,553			7,553	7,553
Ending balance at Sep. 30, 2023	$ 6,661,000		$ 0	$ 0	$ (181,000)	233,852,000	(227,010,000)
Preferred stock, beginning balance (in shares) at Mar. 31, 2023			6,550
Common stock, beginning balance (in shares) at Mar. 31, 2023				2,070,861
Treasury stock, beginning balance (in shares) at Mar. 31, 2023					7,553
Beginning balance at Mar. 31, 2023	3,902,000		$ 0	$ 0	$ (181,000)	229,149,000	(225,066,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,049,000)						(1,049,000)
Stock-based compensation (in shares)				179,535
Stock-based compensation	411,000					411,000
Warrant exercise, net of fees (in shares)				339,498
Warrant exercise, net of fees	534,000					534,000
Release of escrow from March 2023 private placement	4,000,000					4,000,000
Fees associated with Series F Preferred Stock issuance	(38,000)					(38,000)
Conversions of Series F Preferred Stock (in shares)			(175)	146,587
Conversions of Series F Preferred Stock	4,000					4,000
Series F Preferred Stock dividends	(149,000)	$ (148,744)				(149,000)
Preferred stock, ending balance (in shares) at Jun. 30, 2023		6,375	6,375
Common stock, ending balance (in shares) at Jun. 30, 2023				2,736,481
Treasury stock, ending balance (in shares) at Jun. 30, 2023					7,553
Ending balance at Jun. 30, 2023	7,615,000		$ 0	$ 0	$ (181,000)	233,911,000	(226,115,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(895,000)						(895,000)
Stock-based compensation	31,000					31,000
Common stock exchanged for pre-funded warrants (in shares)				(406,776)
Conversions of Series F Preferred Stock (in shares)			(1,229)	1,964,750
Conversions of Series F Preferred Stock	43,000					43,000
Series F Preferred Stock dividends	$ (133,000)	$ (133,364)				(133,000)
Preferred stock, ending balance (in shares) at Sep. 30, 2023	5,146	5,146	5,146
Common stock, ending balance (in shares) at Sep. 30, 2023	4,294,455			4,294,455
Treasury stock, ending balance (in shares) at Sep. 30, 2023	7,553			7,553	7,553
Ending balance at Sep. 30, 2023	$ 6,661,000		$ 0	$ 0	$ (181,000)	$ 233,852,000	$ (227,010,000)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (3,163)	$ (20,724)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	259	1,818
Bad debt (recovery) expense	(55)	114
Non-cash lease expense from right-of-use asset	101	290
Stock-based compensation	473	114
Forfeiture of unvested stock options	0	(84)
Casualty loss (gain), net of insurance proceeds	0	533
Impairment charges - property and equipment	2	37
Impairment charges - intangible assets	0	5,132
Impairment charges - right of use asset	0	179
Impairment charges - goodwill	0	7,367
Changes in operating assets and liabilities:
Accounts receivable	313	378
Inventory	399	261
Prepaid expenses and other current assets	319	213
Other assets	24	56
Accounts payable	(78)	142
Accrued expenses and other current liabilities	(335)	129
Deferred revenue	(354)	(441)
Lease liabilities	(193)	(390)
Net cash used in operating activities	(2,288)	(4,876)
Cash flows from investing activities:
Purchases of property and equipment	0	(11)
Proceeds from sale of equipment	0	30
Net cash provided by investing activities	0	19
Cash flows from financing activities:
Proceeds from private placement, net of issuance costs	5,435	0
Net proceeds from exercise of common stock warrants	534	0
Net cash provided by financing activities	5,969	0
Increase (decrease) in cash	3,681	(4,857)
Cash at beginning of period	3,085	9,000
Cash at end of period	6,766	4,143
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	18	7
Cash paid for income taxes	31	0
Non-cash investing and financing activities:
Preferred stock dividends	282	0
Warrant modification	25	0
Common stock issued for conversion of Preferred Stock and accrued dividends	47	0
Induced exercise of common stock warrants	751	0
Induced exercise of common stock warrants	$ 0	$ 11

Business Description and Signif

Business Description and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Business Description and Significant Accounting Policies	Note 1 - Business Description and Significant Accounting Policies Business Description Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications. Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2022. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2022 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2022 and notes thereto included in the Company's fiscal 2022 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 21, 2023 (the “2022 Annual Report”). The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. On January 3, 2023, the Company effected a 1-for-15 reverse stock split of its Common Stock. All Common Stock share information (including treasury share information) in our Condensed Consolidated Financial Statements and has been adjusted for this stock split retrospectively for all periods represented herein. Principles of Consolidation The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries. Segments The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 10 - Segment Reporting for further discussion. Use of Estimates Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of intangible assets, the inputs used in the valuation of intangible assets in connection with our impairment test, and the inputs used in the fair value of equity-based awards. Significant Accounting Policies The significant accounting policies used in preparation of these Condensed Consolidated Financial Statements are disclosed in our 2022 Annual Report, and there have been no changes to the Company’s significant accounting policies during the nine months ended September 30, 2023. Recently Issued Accounting Pronouncements In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” as amended, which introduced an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. The Company adopted the new guidance, as of January 1, 2023, and it did not have a material impact on the Condensed Consolidated Financial Statements. Casualty Loss In June 2022, the Company discovered that $533,000 of inventory was stolen from the Company’s warehouse in City of Industry, California, and we recorded a casualty loss in operating expenses. During the three months ended June 30, 2023, we recorded a recovery payment from one of our insurance policies of $400,000 as an offset to this casualty loss and in other current assets as of June 30, 2023. We received this recovery payment on July 21, 2023.

Liquidity

Liquidity	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity	Note 2 - Liquidity As of September 30, 2023, we had $6,766,000 in cash and working capital of $6,297,000. For the nine months ended September 30, 2023, we incurred a net loss of $3,163,000 and used $2,288,000 of net cash in operating activities.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Note 3 - Intangible Assets and Goodwill Intangible Assets The following table presents the components of net intangible assets for our Collaboration Products reporting segment (in thousands): As of September 30, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology $ 486 $ (243) $ 243 $ 486 $ (61) $ 425 Trade names 204 (102) 102 204 (25) 179 Total $ 690 $ (345) $ 345 $ 690 $ (86) $ 604 At each reporting period, we determine if there was a triggering event that may result in an impairment of our intangible assets. During the three months ended September 30, 2023, we considered the decline in our stock price to be a triggering event for an impairment test of intangible assets, and during the three months ended March 31, 2023, we considered the declines in revenue for the Collaboration Products reporting segment to be a triggering event for an impairment test of intangible assets for this segment. As the undiscounted cash flows were less than the carrying values of the assets, the company calculated the fair value of the assets. Based on the fair value of the asset group, which was determined using a market approach, no impairment charges were recorded for the three or nine months ended September 30, 2023. During the three and nine months ended September 30, 2022, we considered the declines in revenue for the Collaboration Products reporting segment and the decline in the Company’s market capitalization to be triggering events for an impairment test of intangible assets for this reporting unit. Based on the corresponding recoverability tests of the asset group for this reporting unit, it was determined that the carrying value exceeded the gross cash flows of the asset group. The recoverability test consisted of comparing the estimated undiscounted cash flows expected to be generated by those assets to the respective carrying amounts, and involves significant judgements and assumptions, related primarily to the future revenue and profitability of the assets. Based on the fair value of the asset group, which was determined using a market approach, we recorded impairment charges of $5,132,000 for the three and nine months ended September 30, 2022. Related amortization expense for the three months ended September 30, 2023 and 2022 was $86,000 and $580,000, respectively. Related amortization expense for the nine months ended September 30, 2023 and 2022 was $259,000 and $1,740,000, respectively. Future amortization expense will be as follows (in thousands): Remainder of 2023 $ 87 2024 258 Total $ 345 Goodwill During 2022, goodwill was written down to zero with impairment charges of $7,367,000 during the nine months ended September 30, 2022.

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 30, 2023
Other Liabilities Disclosure [Abstract]
Accrued Expenses and Other Current Liabilities	Note 4 - Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, December 31, 2023 2022 Compensation costs $ 296 $ 707 Customer deposits 167 128 Professional fees 21 57 Taxes and regulatory fees 41 59 Other accrued expenses and liabilities 12 14 Rent expense 202 109 Accrued preferred stock dividends 235 — Accrued expenses and other liabilities $ 974 $ 1,074

Leases

Leases	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	Note 5 - Leases We lease one facility in City of Industry, California, providing warehouse space. This lease expires in February 2024. We currently operate out of remote employment sites with a remote office located at 25587 Conifer Road, Suite 105-231, Conifer, Colorado 80433. Lease expenses including common charges and net of sublet proceeds, for the three months ended September 30, 2023 and 2022, were $35,000 and $92,000, respectively. Lease expenses, including common charges and net of sublet proceeds, for the nine months ended September 30, 2023 and 2022, were $123,000 and $307,000, respectively. Sublease proceeds for the three months ended September 30, 2023 and 2022, were zero and $15,000, respectively. Sublease proceeds for the nine months ended September 30, 2023 and 2022, were $27,000 and $125,000, respectively. The following provides balance sheet information related to leases as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Assets Operating lease, right-of-use asset, net $ 41 $ 142 Liabilities Current portion of operating lease liabilities $ 43 $ 219 Operating lease liabilities, net of current portion — 17 Total operating lease liabilities $ 43 $ 236 During the three months ended September 30, 2023 and 2022, payments of $26,000 and $110,000 were made on leases, respectively. During the nine months ended September 30, 2023 and 2022, payments of $199,000 and $408,000 were made on leases, respectively. The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments 2023 $ 26 2024 17 Total lease payments 43 Effect of discounting (1) — Total lease liability $ 43 (1) The effect of discounting is less than $1,000 due to the term remaining on the lease. The following table provides a reconciliation of activity for our right-of-use (“ROU”) assets and lease liabilities (in thousands): Right-of-Use Asset Operating Lease Liabilities Balance at December 31, 2021 $ 659 $ 728 Additions 11 11 Non-cash lease expense and payments (349) (503) Impairment charges (179) — Balance at December 31, 2022 142 236 Non-cash lease expense and payments (101) (193) Balance at September 30, 2023 $ 41 $ 43

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Capital Stock	Note 6 - Capital Stock Common Stock The Company’s common stock, par value $0.0001 per share (the “Common Stock”), is listed on the Nasdaq Capital Market (“Nasdaq”), under the ticker symbol “OBLG”. As of September 30, 2023, we had 150,000,000 shares of our Common Stock authorized, with 4,294,455 and 4,286,902 shares issued and outstanding, respectively. As of the filing of this report, the Company has 14,955,475 and 14,947,922 shares of Common Stock issued and outstanding, respectively. See Note 12 - Subsequent Events for further information. On April 18, 2023, the Company issued 339,498 shares of Common Stock in relation to certain warrant exercises discussed below, and 177,564 shares of Common Stock related to vested restricted stock units discussed in Note 8 - Stock Based Compensation. On May 28, 2023, in relation to the departure of certain directors, 42 restricted stock awards and 1,929 restricted stock units became fully vested and 1,971 shares of the Company’s common stock were issued. See Note 8 - Stock Based Compensation for further detail. During the three and nine months ended September 30, 2023, 1,229 and 1,404 shares of Series F Preferred Stock, plus accrued dividends, were converted to 1,964,750 and 2,111,337 shares of the Company’s common stock, respectively. See Note 7 - Preferred Stock, for further detail. On June 30, 2023, the Company entered into an exchange agreement (the “Exchange Agreement”) with entities affiliated with Foundry Group (the “Exchanging Stockholders”), pursuant to which the Company exchanged an aggregate of 406,776 shares of the Company’s common stock owned by the Exchanging Stockholders for pre-funded warrants (the “Exchange Warrants”) to purchase an aggregate of 406,776 shares of Common Stock (subject to adjustment in the event of stock splits, recapitalizations and other similar events affecting Common Stock), with an exercise price of $0.0001 per share. The Exchange Warrants are exercisable at any time, except that the Exchange Warrants will not be exercisable by the Exchanging Stockholders if, upon giving effect or immediately prior thereto, the Exchanging Stockholders would beneficially own more than 4.99% of the total number of issued and outstanding Common Stock, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company. The holders of the Exchange Warrants will not have the right to vote on any matter except to the extent required by Delaware law. The shares were exchanged in July 2023, and the returned shares were added back to the authorized and unissued share balance of the Company. Common Stock activity for the nine months ended September 30, 2023 is presented below. The Company did not issue any shares of Common Stock during the year ended December 31, 2022. Issued Shares as of December 31, 2021 2,070,861 Issued Shares as of December 31, 2022 2,070,861 Issuances from Preferred Stock conversions 2,111,337 Issuances related to warrant exercises 339,498 Issuances related to stock compensation 179,535 Common shares exchanged for prepaid warrants (406,776) Issued Shares as of September 30, 2023 4,294,455 Less Treasury Shares: 7,553 Outstanding Shares as of September 30, 2023 4,286,902 Common Stock Warrants On January 3, 2023, the Company and all the holders of the Series A Warrants agreed to amend the terms of the Series A Warrants, issued on June 28, 2021, to extend the termination date from January 4, 2023 to January 4, 2024. All other terms of the Series A Warrants remain in full force and effect. The modification resulted in an incremental value adjustment, and deemed dividend, of $25,000, which was recorded within additional paid-in capital during the three months ended March 31, 2023. On March 30, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which we issued and sold, in a private placement (the “Private Placement”) (i) 6,550 shares of our newly designated Series F Preferred Stock, $0.0001 par value per share (the “Series F Preferred Stock”), (ii) preferred warrants (the “Preferred Warrants”) to acquire 32,750 shares of Series F Preferred Stock, and (iii) common warrants (“Common Warrants” and with the Preferred Warrants the “Investor Warrants”) to acquire up to 3,830,417 shares of Common Stock. Please refer to Note 7 - Preferred Stock for further discussion on the Series F Preferred Stock and Preferred Warrants. In connection with the Private Placement, pursuant to an engagement letter dated March 30, 2023, between the Company and Dawson James Securities, Inc. (the “Placement Agent”), the Company agreed to (i) pay the Placement Agent a cash fee equal to 8% of the aggregate gross proceeds raised in the Private Placement, and (ii) grant to the Placement Agent warrants (the “Placement Agent Warrants”) to purchase 306,433 shares of Common Stock. On March 31, 2023, the Company issued the Common Warrants and the Placement Agent Warrants to purchase an aggregate of 4,136,850 shares of the Company’s Common Stock. The Common Warrants and Placement Agent Warrants have a term of 5 years, commencing six months and one day from the date of issuance, and are initially exercisable for $1.71 per share. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination, recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable exercise price for the Common Warrants (subject to certain exceptions). The Common Warrants and Placement Agent Warrants are exercisable for cash, provided that if there is no effective registration statement available permitting the resale of the common shares, they may be exercised on a cashless basis. Exercise of the Common Warrants and Placement Agent Warrants is subject to certain limitations, including a 4.99% beneficial ownership limitation. The fair value of the warrants was recorded within additional paid-in capital during the three months ended March 31, 2023. On April 18, 2023, the Company entered into warrant exercise inducement offer letters with certain holders of outstanding warrants to purchase shares of the Company’s common stock originally issued on October 21, 2020, December 6, 2020, and June 28, 2021, (such holders the “Exercising Holders” and such warrants the “Existing Warrants”) pursuant to which the Exercising Holders agreed to exercise, for cash, Existing Warrants to purchase, in the aggregate, 339,498 shares of the Company’s common stock (the “ Existing Warrant Shares ”), in exchange for the Company’s agreement to lower the exercise price of the Existing Warrants to $1.71. The Company received net proceeds of $534,000 from the exercise of the Existing Warrants in April 2023 (net of $46,000 of financing costs). The inducement resulted in an incremental value adjustment, and deemed dividend, of $751,000, which was recorded within additional paid-in capital during the three months ended June 30, 2023. Following this transaction, 667, 1,934, and 1,000 warrants remained outstanding of the warrants issued on October 21, 2020, December 6, 2020, and June 28, 2021, respectively. On April 23, 2023, the 667 unexercised warrants issued on October 21, 2020 expired. On June 7, 2023, the 1,934 unexercised warrants issued on December 6, 2020 expired. On October 6, 2023, the Company and Investors holding a majority of the outstanding shares of the Preferred Stock agreed to waive any and all provisions, terms, covenants and obligations in the Certificate of Designations or Common Warrants to the extent such provisions permit the conversion or exercise of the Preferred Stock and the Common Warrants, respectively, to occur at a price below $0.2792. Notwithstanding anything to the contrary in the Common Warrants, the “Exercise Price” as set forth in the Common Warrant shall in no event be less than $0.2792 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events). Warrants outstanding as of September 30, 2023 are as follows: Issue Date Warrants Outstanding Exercise Price Expiration Date June 28, 2021 250 $ 60.00 January 4, 2024 June 28, 2021 750 $ 66.00 December 31, 2024 March 31, 2023 4,136,850 $ 1.71 September 30, 2028 July 3, 2023 406,776 $ 0.0001 None 4,544,626 Warrant activity for the nine months ended September 30, 2023 is presented below. There was no warrant activity during the year ended December 31, 2022. Outstanding Exercisable Number of Warrants Weighted Average Exercise Price Number of Warrants Weighted Average Exercise Price Warrants outstanding and exercisable, December 31, 2021 343,099 $ 66.34 343,099 $ 66.34 Warrants outstanding and exercisable, December 31, 2022 343,099 66.34 343,099 $ 66.34 Granted 4,136,850 1.56 4,136,850 $ 1.56 Exercised (339,498) 1.71 (339,498) $ 1.71 Expired (2,601) 76.93 (2,601) $ 76.93 Warrants outstanding and exercisable, September 30, 2023 4,137,850 $ 1.73 4,137,850 $ 1.73 Treasury Shares The Company maintains treasury stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on transactions related to equity awards. There were no treasury stock transactions during the nine months ended September 30, 2023 or the year ended December 31, 2022.

Preferred Stock

Preferred Stock	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Preferred Stock	Note 7 - Preferred Stock Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of September 30, 2023, we had 1,983,250 designated shares of preferred stock and 5,146 shares of preferred stock issued and outstanding. As of December 31, 2022, we had no shares of preferred stock issued or outstanding. As of the filing of this report, the Company has 2,278 shares of Series F Preferred Stock issued and outstanding. See Note 12 - Subsequent Events for further information. Series F Preferred Stock On March 30, 2023, the Company entered into the Purchase Agreement with Investors, pursuant to which we issued and sold, in a Private Placement (i) 6,550 shares of our newly designated Series F Preferred Stock, (ii) Preferred Warrants to acquire 32,750 shares of Series F Preferred Stock, and (iii) Common Warrants to acquire up to 3,830,417 shares of Common Stock. Please refer to Note 6 - Capital Stock for further discussion on the Common Warrants. The terms of the Series F Preferred Stock are as set forward in the Certificate of Designations of Series F Preferred Stock of Oblong, Inc. (the “Certificate of Designations”), which was filed and became effective with the Secretary of State of the State of Delaware on March 31, 2023. The Private Placement closed on March 31, 2023, in exchange for gross and net proceeds of $6,386,000 and $5,435,000, respectively. All of the Preferred Shares and Investor Warrants were issued at the Closing, but part of the purchase price equivalent to $4,000,000 was placed into an escrow account with American Stock Transfer & Trust Company (the “Escrow”), to be released upon our obtaining stockholder approval permitting the issuance of more than 19.99% of our outstanding shares of Common Stock at less than the Minimum Price (as defined under the Nasdaq Rules) in accordance with Nasdaq listing standards and as otherwise may be required (the “Stockholder Approval”). The Company received the Stockholder Approval via a Special Meeting of Stockholders held on May 18, 2023, and the funds were released from escrow. During the nine months ended September 30, 2023, the Company recorded $5,435,000 in net proceeds. The financing fees associated with the Purchase Agreement were $951,000. The Series F Preferred Shares are convertible into fully paid and non-assessable shares of the Company’s Common Stock at the election of the holder at any time at an initial conversion price of $1.71 (the “Conversion Price”). The holders of the Series F Preferred Shares may also elect to convert their shares at an alternative conversion price equal to the lower of (i) 80% of the applicable Conversion Price as in effect on the date of the conversion, (ii) 80% of the closing price on the trading day immediately preceding the delivery of the conversion notice, and (iii) the greater of (a) the Floor Price (as defined in the Certificate of Designations) and (b) the quotient of (x) the sum of the five lowest Closing Bid Prices (as defined in the Certificate of Designations) for trading days in the 30 consecutive trading day period ending and including the trading day immediately preceding the delivery of the applicable Conversion Notice, divided by (y) five. The Conversion Price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of our common stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable Conversion Price (subject to certain exceptions). On October 6, 2023, the Company and Investors holding a majority of the outstanding shares of the Preferred Stock agreed to waive any and all provisions, terms, covenants and obligations in the Certificate of Designations or Common Warrants to the extent such provisions permit the conversion or exercise of the Preferred Stock and the Common Warrants, respectively, to occur at a price below $0.2792. Notwithstanding anything to the contrary in the Certificate of Designations, each of the “Alternate Conversion Price” and the “Floor Price” as set forth in the Certificate of Designations shall in no event be less than $0.2792 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events). Under the Certificate of Designations, the Series F Preferred Shares have an initial stated value of $1,000 per share (the “Stated Value”). The holders of the Series F Preferred Shares are entitled to dividends of 9% per annum, which will be payable in arrears quarterly. Accrued dividends may be paid, at our option, in cash and if not paid, shall increase the stated value of the Series F Preferred Shares. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Series F Preferred Shares will accrue dividends at the rate of 20% per annum (the “Default Rate”). The Series F Preferred Shares have no voting rights, other than with respect to certain matters affecting the rights of the Series F Preferred Shares. On matters with respect to which the holders of the Series F Preferred Shares have a right to vote, holders of the Preferred Shares will have voting rights on an as-converted basis. Our ability to settle conversions is subject to certain limitations set forth in the Certificate of Designations. Further, the Certificate of Designations contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion of the Series F Preferred Shares. The Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other things, (i) the failure to file and maintain an effective registration statement covering the sale of the holder’s securities registrable pursuant to the Registration Rights Agreement, (ii) the failure to pay any amounts due to the holders of the Series F Preferred Shares when due, and (iii) if Peter Holst ceases to be the chief executive officer of the Company other than because of his death, and a qualified replacement, reasonably acceptable to a majority of the holders of the Series F Preferred Shares, is not appointed within thirty (30) business days. In connection with a Triggering Event, the Default Rate is triggered. We are subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, acquisition transactions, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), maintenance of properties and the transfer of assets, among other matters. During the three and nine months ended September 30, 2023, 1,229 and 1,404 shares of Series F Preferred Stock, plus accrued dividends, were converted to 1,964,750 and 2,111,337 shares of the Company’s common stock, respectively. There were 5,146 shares of Series F Preferred Stock outstanding and accrued dividends of $235,502 as of September 30, 2023. Series F Preferred Stock transactions are summarized in the table below: Series F Preferred Stock Shares Accrued Dividends Weighted Average Conversion Price Common Shares Issued from Conversions March 31, 2023 Issuance 6,550 $ — Q2 2023 Accrued Dividends 148,744 Q2 2023 Conversions (175) (3,665) $ 1.22 146,587 June 30, 2023 Balance 6,375 $ 145,079 146,587 Q3 2023 Accrued Dividends 133,364 Q3 2023 Conversions (1,229) (42,941) $ 0.65 1,964,750 September 30, 2023 Balance 5,146 $ 235,502 2,111,337 Series F Preferred Stock Warrants The Preferred Warrants are exercisable for Series F Preferred Shares at an exercise price of $975. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalizations or other similar transactions involving the Common Stock. The Preferred Warrants expire three years from the date of issuance and are exercisable for cash. For each Preferred Warrant exercised, the Investors shall receive Common Warrants to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock the Investors would receive if the Series F Preferred Shares issuable upon exercise of such Warrant were converted at the applicable Conversion Price. The fair value of the Preferred Warrants was recorded within additional paid-in capital during the nine months ended September 30, 2023. As of September 30, 2023, no Preferred Warrants have been exercised.

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation	Note 8 - Stock Based Compensation 2019 Equity Incentive Plan On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of December 31, 2022, the share pool available for new grants under the 2019 Plan was 177,567. On April 18, 2023, 177,564 restricted stock units were granted to certain members of the board, reducing the share pool available for new grants under the 2019 Plan to 3. A summary of stock compensation expense by category, for the three and nine months ended September 30, 2023 and 2022, is as follows: Three Months Ended September 30, Nine Months Ended September 30, Stock Based Compensation 2023 2022 2023 2022 Options $ 31 $ 31 $ 93 $ 30 RSU — — 380 — Total $ 31 $ 31 $ 473 $ 30 A summary of stock compensation by department, for the three and nine months ended September 30, 2023 and 2022 is as follows: Three Months Ended September 30, Nine Months Ended September 30, Stock Based Compensation 2023 2022 2023 2022 Research and Development $ — $ — $ — $ (63) General & Administrative 31 31 473 93 Total $ 31 $ 31 $ 473 $ 30 Stock Options During the nine months ended September 30, 2023, no stock options were granted, 3,336 stock options vested, and 6,668 vested stock options expired. During the nine months ended September 30, 2022, no stock options were granted, 501 vested stock options expired, and 10,000 unvested stock options were forfeited. A summary of stock options granted, expired, and forfeited under our plans, and options outstanding as of, and changes made during the nine months ended September 30, 2023 and year ended December 31, 2022 is presented below: Outstanding Exercisable Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price Options outstanding and exercisable, December 31, 2021 27,169 $ 113.63 7,169 $ — Vested — — 3,332 48.75 Expired (501) 410.18 (501) 410.18 Forfeited (10,000) 48.75 — — Options outstanding and exercisable, December 31, 2022 16,668 143.63 10,000 206.85 Vested — — 3,336 48.75 Expired (6,668) 285.89 (6,668) 285.89 Options outstanding and exercisable, September 30, 2023 10,000 $ 48.75 6,668 $ 48.75 Additional information as of September 30, 2023 is as follows: Outstanding Exercisable Range of price Number Weighted Weighted Number Weighted $0.00 – $100.00 10,000 7.75 $ 48.75 6,668 $ 48.75 The intrinsic value of vested and unvested options was not significant for all periods presented. Stock compensation expense related to stock options for the three months ended September 30, 2023 and 2022 was $31,000. Stock compensation expense related to stock options for the nine months ended September 30, 2023 was $93,000, and net stock compensation expense related to stock options for the nine months ended September 30, 2022 was $30,000, made up of $114,000 in expense offset by $84,000 related to forfeiture credits. The remaining unrecognized stock-based compensation expense for options as of September 30, 2023 is $92,000, which will be recognized over a weighted average period of 0.75 years. Restricted Stock Awards On May 28, 2023, in relation to the departure of certain directors, 42 restricted stock awards became fully vested and were delivered in shares of the Company’s common stock. The awards were issued in 2014 and vested over the lesser of ten years, a change in control, or separation from the company. As of September 30, 2023, there were no unvested restricted stock awards outstanding and there is no unrecognized stock-based compensation expense for restricted stock awards. There was no stock compensation expense related to restricted stock awards during the three and nine months ended September 30, 2023 and 2022. Restricted Stock Units On April 18, 2023, 177,564 restricted stock units (“RSUs”) were granted to certain board members. These RSUs vested immediately upon issuance. The closing price per share of the Company’s common stock was $2.14 on the day prior to the grant date, resulting in a total fair value of $380,000 which was included in general and administrative expense, as stock-based compensation expense, upon issuance. On May 28, 2023, in relation to the departure of certain directors, 1,929 fully vested RSUs were delivered in shares of the Company’s common stock, in accordance with the terms of the RSUs.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	Note 9 - Net Loss Per Share On January 3, 2023, the Company effected a 1-for-15 reverse stock split for its Common Stock. All Common Stock share information in the following net loss per share discussion and tables are shown as adjusted for this stock split retrospectively for all periods represented herein. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at September 30, 2022, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, warrants, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three and nine months ended September 30, 2023 and 2022, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss). The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (895) $ (7,152) $ (3,163) $ (20,724) Less: deemed dividend (133) — (282) — Less: induced conversion on warrants — — (751) — Less: warrant modification — — (25) — Net loss attributable to common stockholders $ (1,028) $ (7,152) $ (4,221) $ (20,724) Denominator: Weighted-average number of shares of common stock for basic and diluted net loss per share 3,463 2,065 2,676 2,065 Basic and diluted net loss per share $ (0.30) $ (3.46) $ (1.58) $ (10.04) The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): As of September 30, 2023 2022 Unvested restricted stock awards — 42 Outstanding stock options 10,000 16,668 Common stock issuable upon conversion of Series F Preferred Stock 18,850,645 — Common stock issuable upon conversion of Series F Preferred Warrants 117,299,427 — Common stock issuable upon conversion of Common Stock warrants 4,137,850 343,101

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment Reporting	Note 10 - Segment Reporting The Company currently operates in two segments: (1) “Managed Services”, which represents the business surrounding managed services for video collaboration and network applications; and (2) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings. Certain information concerning the Company’s segments for the three and nine months ended September 30, 2023 and 2022 is presented in the following tables (in thousands): Three Months Ended September 30, 2023 Managed Services Collaboration Products Corporate Total Revenue $ 603 $ 269 $ — $ 872 Cost of revenues 398 250 — 648 Gross profit $ 205 $ 19 $ — $ 224 Gross profit % 34 % 7 % 26 % Allocated operating expenses $ — $ 151 $ — $ 151 Unallocated operating expenses — — 998 998 Total operating expenses $ — $ 151 $ 998 $ 1,149 Income (loss) from operations $ 205 $ (132) $ (998) $ (925) Interest and other (income) expense, net (35) 5 — (30) Net income (loss) before tax 240 (137) (998) (895) Income tax expense — — — — Net income (loss) $ 240 $ (137) $ (998) $ (895) Three Months Ended September 30, 2022 Managed Services Collaboration Products Corporate Total Revenue $ 797 $ 388 $ — $ 1,185 Cost of revenues 552 289 — 841 Gross profit $ 245 $ 99 $ — $ 344 Gross profit % 31 % 26 % 29 % Allocated operating expenses $ — $ 6,425 $ — $ 6,425 Unallocated operating expenses — — 1,079 1,079 Total operating expenses $ — $ 6,425 $ 1,079 $ 7,504 Income (loss) from operations $ 245 $ (6,326) $ (1,079) $ (7,160) Interest and other expense (income), net 1 (6) — (5) Income (loss) before income taxes 244 (6,320) (1,079) (7,155) Income tax benefit — (3) — (3) Net income (loss) $ 244 $ (6,317) $ (1,079) $ (7,152) Nine Months Ended September 30, 2023 Managed Services Collaboration Products Corporate Total Revenue $ 1,933 $ 933 $ — $ 2,866 Cost of revenues 1,288 956 — 2,244 Gross profit (loss) $ 645 $ (23) $ — $ 622 Gross profit (loss)% 33 % (2) % 22 % Allocated operating expenses $ 3 $ 61 $ — $ 64 Unallocated operating expenses — — 3,777 3,777 Total operating expenses $ 3 $ 61 $ 3,777 $ 3,841 Income (loss) from operations $ 642 $ (84) $ (3,777) $ (3,219) Interest and other income, net (69) (25) — (94) Net income (loss) before tax 711 (59) (3,777) (3,125) Income tax expense 7 31 — 38 Net income (loss) $ 704 $ (90) $ (3,777) $ (3,163) Nine Months Ended September 30, 2022 Managed Services Collaboration Products Corporate Total Revenue $ 2,573 $ 1,477 $ — $ 4,050 Cost of revenues 1,722 1,078 — 2,800 Gross profit $ 851 $ 399 $ — $ 1,250 Gross profit % 33 % 27 % 31 % Allocated operating expenses $ 57 $ 17,954 $ — $ 18,011 Unallocated operating expenses — — 3,954 3,954 Total operating expenses $ 57 $ 17,954 $ 3,954 $ 21,965 Income (loss) from operations $ 794 $ (17,555) $ (3,954) $ (20,715) Interest and other expense (income), net 7 (6) — 1 Net income (loss) before tax 787 (17,549) (3,954) (20,716) Income tax expense 8 — — 8 Net income (loss) $ 779 $ (17,549) $ (3,954) $ (20,724) Unallocated operating expenses in Corporate include costs for the three and nine months ended September 30, 2023 and 2022 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. For the three months ended September 30, 2023, 11% of our revenue was attributable to the United Kingdom. For the three months ended September 30, 2022, 10% of our revenue was attributable to Singapore. For the nine months ended September 30, 2023 and 2022, there was no material revenue attributable to any individual foreign country. Revenue by geographic area is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Domestic $ 356 $ 575 $ 1,356 $ 2,120 Foreign 516 610 1,510 1,930 $ 872 $ 1,185 $ 2,866 $ 4,050 Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands): Three Months Ended September 30, 2023 % of Revenue 2022 % of Revenue Revenue: Managed Services Video collaboration services $ 38 4 % $ 69 6 % Network services 557 64 % 716 60 % Professional and other services 8 1 % 12 1 % Total Managed Services revenue $ 603 69 % $ 797 67 % Revenue: Collaboration Products Visual collaboration product offerings $ 268 31 % $ 385 33 % Professional services 1 — % — — % Licensing — — % 3 — % Total Collaboration Products revenue 269 31 % 388 33 % Total revenue $ 872 100 % $ 1,185 100 % Nine Months Ended September 30, 2023 % of Revenue 2022 % of Revenue Revenue: Managed Services Video collaboration services $ 148 5 % $ 264 7 % Network services 1,758 61 % 2,260 56 % Professional and other services 27 1 % 49 1 % Total Managed Services revenue $ 1,933 67 % $ 2,573 64 % Revenue: Collaboration Products Visual collaboration product offerings $ 932 33 % $ 1,467 36 % Professional services 1 — % — — % Licensing — — % 10 — % Total Collaboration Products revenue 933 33 % 1,477 36 % Total revenue $ 2,866 100 % $ 4,050 100 % The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition and results of operations. Concentration of revenues was as follows: Three Months Ended September 30, 2023 2022 Segment % of Revenue % of Revenue Customer A Managed Services 60 % 53 % Nine Months Ended September 30, 2023 2022 Segment % of Revenue % of Revenue Customer A Managed Services 56 % 48 % Concentration of accounts receivable was as follows: As of September 30, 2023 2023 2022 Segment % of Accounts Receivable % of Accounts Receivable Customer A Managed Services — % 52 % Customer B Collaboration Products 38 % — % Customer C Collaboration Products — % 12 % Customer D Collaboration Products 12 % — %

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11 - Commitments and Contingencies From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity. COVID-19 On March 11, 2020, the World Health Organization (“WHO”) announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, 2020, the U.S. President announced a National Emergency relating to the disease. In May 2023, the WHO declared COVID-19 over as a global health emergency. Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. Revenue declines for our Collaboration Products business are primarily attributable to the aftermath of the COVID-19 pandemic on our existing and target customers as they continue to evaluate behavioral changes in how and when employees choose to work from traditional office environments, resulting in delayed buying decisions for our Collaboration Products.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsAs of the filing of this Report, the Company has 14,955,475 and 14,947,922 shares of common stock issued and outstanding, respectively, and 2,278 shares of Series F Convertible Preferred Stock issued and outstanding. From October 1, 2023 through the filing of this Report, the Company has issued 10,661,020 shares of common stock pursuant to conversions of its Series F Convertible Preferred Stock.

Business Description and Sign_2

Business Description and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2022. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2022 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2022 and notes thereto included in the Company's fiscal 2022 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 21, 2023 (the “2022 Annual Report”).
Principles of Consolidation	Principles of Consolidation The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.
Segments	Segments The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 10 - Segment Reporting for further discussion.
Use of Estimates	Use of Estimates Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” as amended, which introduced an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. The Company adopted the new guidance, as of January 1, 2023, and it did not have a material impact on the Condensed Consolidated Financial Statements.

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table presents the components of net intangible assets for our Collaboration Products reporting segment (in thousands): As of September 30, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology $ 486 $ (243) $ 243 $ 486 $ (61) $ 425 Trade names 204 (102) 102 204 (25) 179 Total $ 690 $ (345) $ 345 $ 690 $ (86) $ 604
Schedule of Future Amortization Expense	Future amortization expense will be as follows (in thousands): Remainder of 2023 $ 87 2024 258 Total $ 345

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2023
Other Liabilities Disclosure [Abstract]
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, December 31, 2023 2022 Compensation costs $ 296 $ 707 Customer deposits 167 128 Professional fees 21 57 Taxes and regulatory fees 41 59 Other accrued expenses and liabilities 12 14 Rent expense 202 109 Accrued preferred stock dividends 235 — Accrued expenses and other liabilities $ 974 $ 1,074

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Schedule of Balance Sheet Information	The following provides balance sheet information related to leases as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Assets Operating lease, right-of-use asset, net $ 41 $ 142 Liabilities Current portion of operating lease liabilities $ 43 $ 219 Operating lease liabilities, net of current portion — 17 Total operating lease liabilities $ 43 $ 236
Schedule of Future Minimum Rental Payments for Operating Leases	The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments 2023 $ 26 2024 17 Total lease payments 43 Effect of discounting (1) — Total lease liability $ 43 (1) The effect of discounting is less than $1,000 due to the term remaining on the lease.
Schedule Of Operating Lease Liability and Right Of Use Assets	The following table provides a reconciliation of activity for our right-of-use (“ROU”) assets and lease liabilities (in thousands): Right-of-Use Asset Operating Lease Liabilities Balance at December 31, 2021 $ 659 $ 728 Additions 11 11 Non-cash lease expense and payments (349) (503) Impairment charges (179) — Balance at December 31, 2022 142 236 Non-cash lease expense and payments (101) (193) Balance at September 30, 2023 $ 41 $ 43

Capital Stock (Tables)

Capital Stock (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of Common Stock Activity	Common Stock activity for the nine months ended September 30, 2023 is presented below. The Company did not issue any shares of Common Stock during the year ended December 31, 2022. Issued Shares as of December 31, 2021 2,070,861 Issued Shares as of December 31, 2022 2,070,861 Issuances from Preferred Stock conversions 2,111,337 Issuances related to warrant exercises 339,498 Issuances related to stock compensation 179,535 Common shares exchanged for prepaid warrants (406,776) Issued Shares as of September 30, 2023 4,294,455 Less Treasury Shares: 7,553 Outstanding Shares as of September 30, 2023 4,286,902
Schedule of Warrants Activity	Warrants outstanding as of September 30, 2023 are as follows: Issue Date Warrants Outstanding Exercise Price Expiration Date June 28, 2021 250 $ 60.00 January 4, 2024 June 28, 2021 750 $ 66.00 December 31, 2024 March 31, 2023 4,136,850 $ 1.71 September 30, 2028 July 3, 2023 406,776 $ 0.0001 None 4,544,626 Warrant activity for the nine months ended September 30, 2023 is presented below. There was no warrant activity during the year ended December 31, 2022. Outstanding Exercisable Number of Warrants Weighted Average Exercise Price Number of Warrants Weighted Average Exercise Price Warrants outstanding and exercisable, December 31, 2021 343,099 $ 66.34 343,099 $ 66.34 Warrants outstanding and exercisable, December 31, 2022 343,099 66.34 343,099 $ 66.34 Granted 4,136,850 1.56 4,136,850 $ 1.56 Exercised (339,498) 1.71 (339,498) $ 1.71 Expired (2,601) 76.93 (2,601) $ 76.93 Warrants outstanding and exercisable, September 30, 2023 4,137,850 $ 1.73 4,137,850 $ 1.73

Preferred Stock (Tables)

Preferred Stock (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of Series F Preferred Stock Transactions	Series F Preferred Stock transactions are summarized in the table below: Series F Preferred Stock Shares Accrued Dividends Weighted Average Conversion Price Common Shares Issued from Conversions March 31, 2023 Issuance 6,550 $ — Q2 2023 Accrued Dividends 148,744 Q2 2023 Conversions (175) (3,665) $ 1.22 146,587 June 30, 2023 Balance 6,375 $ 145,079 146,587 Q3 2023 Accrued Dividends 133,364 Q3 2023 Conversions (1,229) (42,941) $ 0.65 1,964,750 September 30, 2023 Balance 5,146 $ 235,502 2,111,337

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Compensation Expense	A summary of stock compensation expense by category, for the three and nine months ended September 30, 2023 and 2022, is as follows: Three Months Ended September 30, Nine Months Ended September 30, Stock Based Compensation 2023 2022 2023 2022 Options $ 31 $ 31 $ 93 $ 30 RSU — — 380 — Total $ 31 $ 31 $ 473 $ 30 A summary of stock compensation by department, for the three and nine months ended September 30, 2023 and 2022 is as follows: Three Months Ended September 30, Nine Months Ended September 30, Stock Based Compensation 2023 2022 2023 2022 Research and Development $ — $ — $ — $ (63) General & Administrative 31 31 473 93 Total $ 31 $ 31 $ 473 $ 30
Schedule of Options Granted, Exercised, Expired and Forfeited	A summary of stock options granted, expired, and forfeited under our plans, and options outstanding as of, and changes made during the nine months ended September 30, 2023 and year ended December 31, 2022 is presented below: Outstanding Exercisable Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price Options outstanding and exercisable, December 31, 2021 27,169 $ 113.63 7,169 $ — Vested — — 3,332 48.75 Expired (501) 410.18 (501) 410.18 Forfeited (10,000) 48.75 — — Options outstanding and exercisable, December 31, 2022 16,668 143.63 10,000 206.85 Vested — — 3,336 48.75 Expired (6,668) 285.89 (6,668) 285.89 Options outstanding and exercisable, September 30, 2023 10,000 $ 48.75 6,668 $ 48.75
Schedule of Shares Outstanding and Exercisable, By Exercise Price Range	Additional information as of September 30, 2023 is as follows: Outstanding Exercisable Range of price Number Weighted Weighted Number Weighted $0.00 – $100.00 10,000 7.75 $ 48.75 6,668 $ 48.75

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (895) $ (7,152) $ (3,163) $ (20,724) Less: deemed dividend (133) — (282) — Less: induced conversion on warrants — — (751) — Less: warrant modification — — (25) — Net loss attributable to common stockholders $ (1,028) $ (7,152) $ (4,221) $ (20,724) Denominator: Weighted-average number of shares of common stock for basic and diluted net loss per share 3,463 2,065 2,676 2,065 Basic and diluted net loss per share $ (0.30) $ (3.46) $ (1.58) $ (10.04)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): As of September 30, 2023 2022 Unvested restricted stock awards — 42 Outstanding stock options 10,000 16,668 Common stock issuable upon conversion of Series F Preferred Stock 18,850,645 — Common stock issuable upon conversion of Series F Preferred Warrants 117,299,427 — Common stock issuable upon conversion of Common Stock warrants 4,137,850 343,101

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Certain information concerning the Company’s segments for the three and nine months ended September 30, 2023 and 2022 is presented in the following tables (in thousands): Three Months Ended September 30, 2023 Managed Services Collaboration Products Corporate Total Revenue $ 603 $ 269 $ — $ 872 Cost of revenues 398 250 — 648 Gross profit $ 205 $ 19 $ — $ 224 Gross profit % 34 % 7 % 26 % Allocated operating expenses $ — $ 151 $ — $ 151 Unallocated operating expenses — — 998 998 Total operating expenses $ — $ 151 $ 998 $ 1,149 Income (loss) from operations $ 205 $ (132) $ (998) $ (925) Interest and other (income) expense, net (35) 5 — (30) Net income (loss) before tax 240 (137) (998) (895) Income tax expense — — — — Net income (loss) $ 240 $ (137) $ (998) $ (895) Three Months Ended September 30, 2022 Managed Services Collaboration Products Corporate Total Revenue $ 797 $ 388 $ — $ 1,185 Cost of revenues 552 289 — 841 Gross profit $ 245 $ 99 $ — $ 344 Gross profit % 31 % 26 % 29 % Allocated operating expenses $ — $ 6,425 $ — $ 6,425 Unallocated operating expenses — — 1,079 1,079 Total operating expenses $ — $ 6,425 $ 1,079 $ 7,504 Income (loss) from operations $ 245 $ (6,326) $ (1,079) $ (7,160) Interest and other expense (income), net 1 (6) — (5) Income (loss) before income taxes 244 (6,320) (1,079) (7,155) Income tax benefit — (3) — (3) Net income (loss) $ 244 $ (6,317) $ (1,079) $ (7,152) Nine Months Ended September 30, 2023 Managed Services Collaboration Products Corporate Total Revenue $ 1,933 $ 933 $ — $ 2,866 Cost of revenues 1,288 956 — 2,244 Gross profit (loss) $ 645 $ (23) $ — $ 622 Gross profit (loss)% 33 % (2) % 22 % Allocated operating expenses $ 3 $ 61 $ — $ 64 Unallocated operating expenses — — 3,777 3,777 Total operating expenses $ 3 $ 61 $ 3,777 $ 3,841 Income (loss) from operations $ 642 $ (84) $ (3,777) $ (3,219) Interest and other income, net (69) (25) — (94) Net income (loss) before tax 711 (59) (3,777) (3,125) Income tax expense 7 31 — 38 Net income (loss) $ 704 $ (90) $ (3,777) $ (3,163) Nine Months Ended September 30, 2022 Managed Services Collaboration Products Corporate Total Revenue $ 2,573 $ 1,477 $ — $ 4,050 Cost of revenues 1,722 1,078 — 2,800 Gross profit $ 851 $ 399 $ — $ 1,250 Gross profit % 33 % 27 % 31 % Allocated operating expenses $ 57 $ 17,954 $ — $ 18,011 Unallocated operating expenses — — 3,954 3,954 Total operating expenses $ 57 $ 17,954 $ 3,954 $ 21,965 Income (loss) from operations $ 794 $ (17,555) $ (3,954) $ (20,715) Interest and other expense (income), net 7 (6) — 1 Net income (loss) before tax 787 (17,549) (3,954) (20,716) Income tax expense 8 — — 8 Net income (loss) $ 779 $ (17,549) $ (3,954) $ (20,724) Concentration of revenues was as follows: Three Months Ended September 30, 2023 2022 Segment % of Revenue % of Revenue Customer A Managed Services 60 % 53 % Nine Months Ended September 30, 2023 2022 Segment % of Revenue % of Revenue Customer A Managed Services 56 % 48 % Concentration of accounts receivable was as follows: As of September 30, 2023 2023 2022 Segment % of Accounts Receivable % of Accounts Receivable Customer A Managed Services — % 52 % Customer B Collaboration Products 38 % — % Customer C Collaboration Products — % 12 % Customer D Collaboration Products 12 % — %
Schedule of Revenue from External Customers by Geographic Areas	Revenue by geographic area is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Domestic $ 356 $ 575 $ 1,356 $ 2,120 Foreign 516 610 1,510 1,930 $ 872 $ 1,185 $ 2,866 $ 4,050
Schedule of Disaggregated Revenue Information	Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands): Three Months Ended September 30, 2023 % of Revenue 2022 % of Revenue Revenue: Managed Services Video collaboration services $ 38 4 % $ 69 6 % Network services 557 64 % 716 60 % Professional and other services 8 1 % 12 1 % Total Managed Services revenue $ 603 69 % $ 797 67 % Revenue: Collaboration Products Visual collaboration product offerings $ 268 31 % $ 385 33 % Professional services 1 — % — — % Licensing — — % 3 — % Total Collaboration Products revenue 269 31 % 388 33 % Total revenue $ 872 100 % $ 1,185 100 % Nine Months Ended September 30, 2023 % of Revenue 2022 % of Revenue Revenue: Managed Services Video collaboration services $ 148 5 % $ 264 7 % Network services 1,758 61 % 2,260 56 % Professional and other services 27 1 % 49 1 % Total Managed Services revenue $ 1,933 67 % $ 2,573 64 % Revenue: Collaboration Products Visual collaboration product offerings $ 932 33 % $ 1,467 36 % Professional services 1 — % — — % Licensing — — % 10 — % Total Collaboration Products revenue 933 33 % 1,477 36 % Total revenue $ 2,866 100 % $ 4,050 100 %

Business Description and Sign_3

Business Description and Significant Accounting Policies (Details) $ in Thousands		1 Months Ended	3 Months Ended	9 Months Ended
	Jan. 03, 2023	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2023 USD ($) segment	Sep. 30, 2022 USD ($)
Accounting Policies [Abstract]
Number of operating segments | segment				2
Stockholders' equity note, stock split, conversion ratio	0.06667
Casualty loss (gain), net of insurance proceeds		$ 533		$ 0	$ 533
Insurance recoveries			$ 400

Liquidity (Details)

Liquidity (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 6,766			$ 4,143			$ 6,766	$ 4,143	$ 3,085	$ 9,000
Working capital	6,297						6,297
Net loss	$ 895	$ 1,049	$ 1,219	$ 7,152	$ 9,033	$ 4,539	3,163	20,724
Net cash used in operating activities							$ 2,288	$ 4,876

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Gross Carrying Amount	$ 690	$ 690
Accumulated Amortization	(345)	(86)
Net Carrying Amount	345	604
Developed technology
Business Acquisition [Line Items]
Gross Carrying Amount	486	486
Accumulated Amortization	(243)	(61)
Net Carrying Amount	243	425
Trade names
Business Acquisition [Line Items]
Gross Carrying Amount	204	204
Accumulated Amortization	(102)	(25)
Net Carrying Amount	$ 102	$ 179

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment charges - intangible assets	$ 0	$ 5,132,000	$ 0	$ 5,132,000
Amortization expense	$ 86,000	$ 580,000	259,000	1,740,000
Goodwill					$ 0
Impairment charges - goodwill			$ 0	$ 7,367,000

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 87
2024	258
Total	$ 345	$ 604

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Compensation costs	$ 296	$ 707
Customer deposits	167	128
Professional fees	21	57
Taxes and regulatory fees	41	59
Other accrued expenses and liabilities	12	14
Rent expense	202	109
Accrued preferred stock dividends	235	0
Accrued expenses and other liabilities	$ 974	$ 1,074

Leases - Narrative (Details)

Leases - Narrative (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) facility	Sep. 30, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Non-cash lease expense	$ 35,000	$ 92,000	$ 123,000	$ 307,000
Sublease income	0	15,000	27,000	125,000
Operating lease, payments	$ 26,000	$ 110,000	$ 199,000	$ 408,000
City of Industry, California
Lessee, Lease, Description [Line Items]
Number of facilities | facility			1

Leases - Balance Sheet Informat

Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease - right of use asset, net	$ 41	$ 41	$ 142	$ 659
Current portion of operating lease liabilities	43		219
Operating lease liabilities, net of current portion	0		17
Total operating lease liabilities	$ 43	$ 43	$ 236	$ 728

Leases - Table Operating Lease

Leases - Table Operating Lease Future Minimum Rental Commitment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
2023	$ 26
2024	17
Total lease payments	43
Effect of discounting	0
Total lease liability	$ 43	$ 43	$ 236	$ 728

Leases - Summary of Activity fo

Leases - Summary of Activity for Our Right of Use Assets And Lease Liabilities (Details) - USD ($) $ in Thousands	6 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Right-of-Use Asset
Beginning balance	$ 142	$ 142	$ 659	$ 659
Additions				11
Non-cash lease expense and payments	(101)	(101)	(290)	(349)
Impairment charges		0	(179)	(179)
Ending balance	41	41		142
Operating Lease Liabilities
Beginning balance	236	236	$ 728	728
Additions				11
Non-cash lease expense and payments	(193)			(503)
Impairment charges				0
Ending balance	$ 43	$ 43		$ 236

Capital Stock - Common Stock (D

Capital Stock - Common Stock (Details) - $ / shares				3 Months Ended		6 Months Ended	9 Months Ended
	Jun. 30, 2023	May 28, 2023	Apr. 18, 2023	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2023	Nov. 08, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Common stock, par value (in dollars per share)				$ 0.0001		$ 0.0001	$ 0.0001			$ 0.0001
Common stock, shares authorized (in shares)				150,000,000		150,000,000	150,000,000			150,000,000
Common stock, shares issued (in shares)				4,294,455		4,294,455	4,294,455			2,070,861
Common stock, shares outstanding (in shares)				4,286,902		4,286,902	4,286,902			2,063,308
Exercise price (in dollars per share)				$ 1.73		$ 1.73	$ 1.73			$ 66.34				$ 66.34
Subsequent Event
Class of Stock [Line Items]
Common stock, shares issued (in shares)								14,955,475
Common stock, shares outstanding (in shares)								14,947,922
Exchange Agreement
Class of Stock [Line Items]
Number of shares issued (in shares)	406,776
Exchange Agreement | Exchange Warrants
Class of Stock [Line Items]
Number of shares issuable (in shares)	406,776				406,776
Exercise price (in dollars per share)	$ 0.0001				$ 0.0001
Beneficial ownership limitation (in percent)	4.99%				4.99%
Notice period to increase beneficial ownership limitation	61 days
Exchange Agreement | Exchange Warrants | Maximum
Class of Stock [Line Items]
Beneficial ownership limitation (in percent)	19.99%				19.99%
Series F Preferred Stock
Class of Stock [Line Items]
Shares converted (in shares)				1,229			1,404
Exercise price (in dollars per share)				$ 975		$ 975	$ 975
Director
Class of Stock [Line Items]
Stock-based compensation (in shares)		1,971
Director | Restricted Stock
Class of Stock [Line Items]
Vested, restricted shares (in shares)		42
Director | RSUs
Class of Stock [Line Items]
Vested, restricted shares (in shares)		1,929
Common Stock
Class of Stock [Line Items]
Common stock, shares issued (in shares)	2,736,481			4,294,455	2,736,481	4,294,455	4,294,455		2,070,861	2,070,861		2,070,861	2,070,861	2,070,861
Common stock, shares outstanding (in shares)				4,286,902		4,286,902	4,286,902				2,070,861
Issuance of common shares from warrant exercise (in shares)			339,498				339,498
Issuance of restricted stock (in shares)			177,564
Stock-based compensation (in shares)					179,535		179,535
Common shares issued in conversion (in shares)				1,964,750	146,587	2,111,337
Exercise price (in dollars per share)			$ 1.71
Common Stock | Series F Preferred Stock
Class of Stock [Line Items]
Common shares issued in conversion (in shares)							2,111,337

Capital Stock - Common Stock Ac

Capital Stock - Common Stock Activity (Details) - shares		3 Months Ended		9 Months Ended
	Apr. 18, 2023	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock, shares (in shares)		7,553		7,553	7,553
Common stock, shares outstanding (in shares)		4,286,902		4,286,902	2,063,308
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)				2,070,861
Issuances from Preferred Stock Conversions (in shares)		1,964,750	146,587	2,111,337
Issuances related to warrant exercises (in shares)	339,498			339,498
Issuances related to stock compensation (in shares)			179,535	179,535
Common shares exchanged for prepaid warrants (in shares)		(406,776)		(406,776)
Ending Balance (in shares)		4,294,455		4,294,455
Ending Balance (in shares)		4,294,455		4,294,455	2,070,861		2,070,861
Treasury stock, shares (in shares)		7,553		7,553
Common stock, shares outstanding (in shares)		4,286,902		4,286,902		2,070,861

Capital Stock - Common Stock Wa

Capital Stock - Common Stock Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

Jun. 07, 2023

Apr. 23, 2023

Apr. 18, 2023

Mar. 30, 2023

Jun. 30, 2023

Mar. 31, 2023

Sep. 30, 2023

Sep. 30, 2022

Oct. 06, 2023

Jul. 03, 2023

Dec. 31, 2022

Dec. 31, 2021

Jun. 28, 2021

Dec. 06, 2020

Oct. 21, 2020

Class of Warrant or Right [Line Items]

Preferred stock, convertible, par value (in dollars per share)

$ 0.0001

$ 0.0001

Warrants issued (in shares)

4,544,626

Warrants outstanding, ending (in dollars per share)

$ 1.73

$ 66.34

$ 66.34

Net proceeds from exercise of common stock warrants

$ 534

$ 0

Warrants outstanding, ending (in shares)

4,137,850

343,099

343,099

Expired (in shares)

1,934

667

2,601

Subsequent Event

Class of Warrant or Right [Line Items]

Weighted average conversion price (in dollars per share)

$ 0.2792

Private Placement | Preferred Warrants

Class of Warrant or Right [Line Items]

Number of shares issuable (in shares)

32,750

Private Placement | Investor Warrants

Class of Warrant or Right [Line Items]

Number of shares issuable (in shares)

3,830,417

Private Placement | Placement Agent Warrants

Class of Warrant or Right [Line Items]

Number of shares issuable (in shares)

306,433

Series F Preferred Stock

Class of Warrant or Right [Line Items]

Proceeds from private placement, net of fees and amounts held in escrow (in shares)

6,550

Warrants outstanding, ending (in dollars per share)

$ 975

Weighted average conversion price (in dollars per share)

$ 1.71

$ 1.22

$ 0.65

Series F Preferred Stock | Private Placement

Class of Warrant or Right [Line Items]

Proceeds from private placement, net of fees and amounts held in escrow (in shares)

6,550

Preferred stock, convertible, par value (in dollars per share)

$ 0.0001

Percentage of cash fees (in percent)

8%

Payments of stock issuance costs

$ 951

Common stock issuable upon conversion of Common Stock warrants

Class of Warrant or Right [Line Items]

Deemed dividend

$ 751

$ 25

Warrants issued (in shares)

4,136,850

406,776

Warrants outstanding, ending (in dollars per share)

$ 1.71

$ 0.0001

Common stock issuable upon conversion of Common Stock warrants | Private Placement

Class of Warrant or Right [Line Items]

Warrant term (in years)

5 years

Beneficial ownership limitation (in percent)

4.99%

Common Stock

Class of Warrant or Right [Line Items]

Warrants outstanding, ending (in dollars per share)

$ 1.71

Issuance of common shares from warrant exercise (in shares)

339,498

339,498

Net proceeds from exercise of common stock warrants

$ 534

Payments of stock issuance costs

$ 46

Warrants outstanding, ending (in shares)

1,000

1,934

667

Capital Stock - Warrants Outsta

Capital Stock - Warrants Outstanding (Details) - $ / shares	Sep. 30, 2023	Jul. 03, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jun. 28, 2021
Class of Warrant or Right [Line Items]
Warrants issued (in shares)	4,544,626
Exercise price (in dollars per share)	$ 1.73			$ 66.34	$ 66.34
Series A Warrants
Class of Warrant or Right [Line Items]
Warrants issued (in shares)						250
Exercise price (in dollars per share)						$ 60
Series B Warrants
Class of Warrant or Right [Line Items]
Warrants issued (in shares)						750
Exercise price (in dollars per share)						$ 66
Warrants
Class of Warrant or Right [Line Items]
Warrants issued (in shares)		406,776	4,136,850
Exercise price (in dollars per share)		$ 0.0001	$ 1.71

Capital Stock - Warrants Activi

Capital Stock - Warrants Activity (Details) - $ / shares			9 Months Ended
	Jun. 07, 2023	Apr. 23, 2023	Sep. 30, 2023	Dec. 31, 2021
Number of Warrants
Warrants outstanding, beginning (in shares)			343,099
Granted (in shares)			4,136,850
Exercised (in shares)			(339,498)
Expired (in shares)	(1,934)	(667)	(2,601)
Warrants outstanding, ending (in shares)			4,137,850
Warrants outstanding, ending (in shares)			4,137,850	343,099
Weighted Average Exercise Price
Warrants outstanding, beginning (in dollars per share)			$ 66.34
Granted (in dollars per share)			1.56
Exercised (in dollars per share)			1.71
Expired (in dollars per share)			76.93
Warrants outstanding, ending (in dollars per share)			1.73
Warrants outstanding, ending (in dollars per share)			$ 1.73	$ 66.34
Number of Warrants
Warrants exercisable, beginning (in shares)			343,099
Granted (in shares)			4,136,850
Exercised (in shares)			(339,498)
Expired (in shares)			(2,601)
Warrants exercisable, ending (in shares)			4,137,850
Warrants exercisable, ending (in shares)			4,137,850	343,099
Weighted Average Exercise Price
Warrants exercisable, beginning (in dollars per share)			$ 66.34
Granted (in dollars per share)			1.56
Exercised (in dollars per share)			1.71
Expired (in dollars per share)			76.93
Warrants exercisable, ending (in dollars per share)			1.73
Warrants exercisable, ending (in dollars per share)			$ 1.73	$ 66.34

Preferred Stock - Narrative (De

Preferred Stock - Narrative (Details) - USD ($)				3 Months Ended		6 Months Ended	9 Months Ended
	Apr. 18, 2023	Mar. 31, 2023	Mar. 30, 2023	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2023	Nov. 08, 2023	Oct. 06, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				42,000		42,000	42,000			42,000
Preferred stock, shares designated (in shares)				1,983,250		1,983,250	1,983,250
Preferred stock, shares issued (in shares)				5,146		5,146	5,146			0
Preferred stock, shares outstanding (in shares)				5,146		5,146	5,146			0
Warrants outstanding, ending (in dollars per share)				$ 1.73		$ 1.73	$ 1.73			$ 66.34	$ 66.34
Common Stock
Class of Stock [Line Items]
Payments of stock issuance costs	$ 46,000
Common shares issued in conversion (in shares)				1,964,750	146,587	2,111,337
Warrants outstanding, ending (in dollars per share)	$ 1.71
Subsequent Event
Class of Stock [Line Items]
Weighted average conversion price (in dollars per share)									$ 0.2792
Private Placement | Preferred Warrants
Class of Stock [Line Items]
Number of shares issuable (in shares)			32,750
Private Placement | Investor Warrants
Class of Stock [Line Items]
Number of shares issuable (in shares)			3,830,417
Series F Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares outstanding (in shares)				5,146	6,375	5,146	5,146
Proceeds from private placement, net of fees and amounts held in escrow (in shares)			6,550
Percentage of common stock to be issued at minimum price			19.99%
Weighted average conversion price (in dollars per share)			$ 1.71	$ 0.65	$ 1.22	$ 0.65	$ 0.65
Preferred stock, conversion price percentage (in percent)			80%
Preferred stock convertible, threshold consecutive trading days			30 days
Preferred stock, liquidation preference per share (in dollars per share)				$ 1,000		$ 1,000	$ 1,000
Preferred stock dividend percentage (in percent)							9%
Shares converted (in shares)				1,229			1,404
Preferred stock dividends		$ 0		$ 235,502	$ 145,079	$ 235,502	$ 235,502
Warrants outstanding, ending (in dollars per share)				$ 975		$ 975	$ 975
Expiration period							3 years
Percentage of common stock issuable (in percent)				100%		100%	100%
Series F Preferred Stock | Common Stock
Class of Stock [Line Items]
Common shares issued in conversion (in shares)							2,111,337
Series F Preferred Stock | Subsequent Event
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)								2,278
Preferred stock, shares outstanding (in shares)								2,278
Series F Preferred Stock | Scenario 1
Class of Stock [Line Items]
Preferred stock dividend percentage (in percent)							20%
Series F Preferred Stock | Private Placement
Class of Stock [Line Items]
Proceeds from private placement, net of fees and amounts held in escrow (in shares)			6,550
Gross proceeds		6,386,000
Proceeds from private placement, net of issuance costs		$ 5,435,000					$ 5,435,000
Escrow deposit			$ 4,000,000
Payments of stock issuance costs							$ 951,000
Maximum
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				5,000,000		5,000,000	5,000,000

Preferred Stock - Series F Pref

Preferred Stock - Series F Preferred Stock Transactions (Details) - USD ($)		3 Months Ended			6 Months Ended	9 Months Ended
	Mar. 30, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Class of Stock [Line Items]
Preferred stock, shares outstanding (in shares)		5,146			5,146	5,146		0
Preferred stock dividends		$ 133,000	$ 149,000			$ 282,000	$ 0
Common Stock
Class of Stock [Line Items]
Conversions of Series F Preferred Stock (in shares)		1,964,750	146,587			2,111,337
Shares issued from conversion (in shares)		1,964,750	146,587		2,111,337
Series F Preferred Stock
Class of Stock [Line Items]
Number of shares issued (in shares)	6,550
Preferred stock, shares outstanding (in shares)		5,146	6,375		5,146	5,146
Accrued dividend		$ 235,502	$ 145,079	$ 0	$ 235,502	$ 235,502
Preferred stock dividends		133,364	148,744
Converted preferred stock, accrued dividends		$ (42,941)	$ (3,665)
Weighted average conversion price (in dollars per share)	$ 1.71	$ 0.65	$ 1.22		$ 0.65	$ 0.65
Series F Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Number of shares issued (in shares)				6,550
Conversions of Series F Preferred Stock (in shares)		(1,229)	(175)
Preferred stock, shares outstanding (in shares)		5,146	6,375	6,550	5,146	5,146		0
Series F Preferred Stock | Common Stock
Class of Stock [Line Items]
Shares issued from conversion (in shares)						2,111,337

Stock Based Compensation - Narr

Stock Based Compensation - Narrative (Details) - USD ($)			3 Months Ended			9 Months Ended		12 Months Ended
	May 28, 2023	Apr. 18, 2023	Sep. 30, 2023	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Apr. 17, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)						0	0
Vested stock options expired (in shares)						6,668		501
Forfeited (in shares)							10,000	10,000
Options, intrinsic value, vested			$ 0	$ 0		$ 0	$ 0
Stock option compensation expense, forfeiture					$ 84,000
Unrecognized stock-based compensation expense for stock options			92,000			92,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense			31,000	31,000		$ 93,000	30,000
Stock option compensation expense, gross							114,000
Stock option compensation expense, forfeiture							84,000
Cost not yet recognized, period for recognition						9 months
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense			$ 0	0		$ 0	0
Unvested restricted shares outstanding (in shares)			0			0
Unrecognized stock-based compensation expense for other than options			$ 0			$ 0
Restricted Stock | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, restricted shares (in shares)	42
Vesting period	10 years
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense			$ 0	0		$ 0	0
Unvested restricted shares outstanding (in shares)			0			0
Unrecognized stock-based compensation expense for other than options			$ 0			$ 0
RSUs | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, restricted shares (in shares)	1,929
2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)			3			3		177,567
Shares granted (in shares)		177,564
Stock option compensation expense			$ 31,000	31,000		$ 473,000	30,000
Share price (in dollars per share)									$ 2.14
2019 Equity Incentive Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense			31,000	31,000		93,000	30,000
2019 Equity Incentive Plan | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense		$ 380,000	$ 0	$ 0		$ 380,000	$ 0

Stock Based Compensation - Stoc

Stock Based Compensation - Stock Compensation Expense (Details) - USD ($)		3 Months Ended		9 Months Ended
	Apr. 18, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense		$ 31,000	$ 31,000	$ 473,000	$ 30,000
Research and Development | 2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense		0	0	0	(63,000)
General & Administrative | 2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense		31,000	31,000	473,000	93,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense		31,000	31,000	93,000	30,000
Stock Options | 2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense		31,000	31,000	93,000	30,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense		0	0	0	0
RSUs | 2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	$ 380,000	$ 0	$ 0	$ 380,000	$ 0

Stock Based Compensation - Opti

Stock Based Compensation - Options Outstanding (Details) - $ / shares	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Number of Options
Outstanding number of options, beginning (in shares)	16,668	27,169	27,169
Vested (in shares)	0		0
Expired (in shares)	(6,668)		(501)
Forfeited (in shares)		(10,000)	(10,000)
Outstanding and exercisable number of options, ending (in shares)	10,000		16,668
Weighted Average Exercise Price
Outstanding weighted average exercise price, beginning (in dollars per share)	$ 143.63	$ 113.63	$ 113.63
Vested (in dollars per share)	0		0
Expired (in dollars per share)	285.89		410.18
Forfeited (in dollars per share)			48.75
Outstanding and exercisable weighted average exercise price, ending (in dollars per share)	$ 48.75		$ 143.63
Exercisable
Exercisable number of options, beginning (in shares)	10,000	7,169	7,169
Vested (in shares)	3,336		3,332
Expired (in shares)	(6,668)		(501)
Exercisable number of options, ending (in shares)	6,668		10,000
Exercisable weighted average exercise price, beginning (in dollars per share)	$ 206.85	$ 0	$ 0
Exercisable vested, weighted average exercise price (in dollars per share)	48.75		48.75
Exercisable expired, weighted average exercise price (in dollars per share)	285.89		410.18
Exercisable weighted average exercise price, ending (in dollars per share)	$ 48.75		$ 206.85

Stock Based Compensation - Exer

Stock Based Compensation - Exercise Price Range (Details) - $ / shares	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of options, outstanding (in shares)	10,000	16,668	27,169
Weighted average exercise price, outstanding (in dollars per share)	$ 48.75	$ 143.63	$ 113.63
Number of options, exercisable (in shares)	6,668	10,000	7,169
Exercisable weighted average exercise price (in dollars per share)	$ 48.75	$ 206.85	$ 0
$0.00 – $100.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	0
Range of price, upper range limit (in dollars per share)	$ 100
Number of options, outstanding (in shares)	10,000
Weighted Average Remaining Contractual Life (In Years)	7 years 9 months
Weighted average exercise price, outstanding (in dollars per share)	$ 48.75
Number of options, exercisable (in shares)	6,668
Exercisable weighted average exercise price (in dollars per share)	$ 48.75

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)		9 Months Ended
	Jan. 03, 2023	Sep. 30, 2023 shares
Earnings Per Share [Abstract]
Stockholders' equity note, stock split, conversion ratio	0.06667
Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares)		0

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net loss	$ (895)	$ (1,049)	$ (1,219)	$ (7,152)	$ (9,033)	$ (4,539)	$ (3,163)	$ (20,724)
Less: deemed dividend	(133)			0			(282)	0
Less: induced conversion on warrants	0			0			(751)	0
Less: warrant modification	0			0			(25)	0
Net loss attributable to common stockholders	$ (1,028)			$ (7,152)			$ (4,221)	$ (20,724)
Denominator:
Weighted-average number of shares of common stock - basic (in shares)	3,463			2,065			2,676	2,065
Weighted-average number of shares of common stock - diluted (in shares)	3,463			2,065			2,676	2,065
Basic net loss per share (in dollars per share)	$ (0.30)			$ (3.46)			$ (1.58)	$ (10.04)
Diluted net loss per share (in dollars per share)	$ (0.30)			$ (3.46)			$ (1.58)	$ (10.04)

Net Loss Per Share - Effect of

Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Unvested restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	42
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	10,000	16,668
Common stock issuable upon conversion of Series F Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	18,850,645	0
Common stock issuable upon conversion of Series F Preferred Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	117,299,427	0
Common stock issuable upon conversion of Common Stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	4,137,850	343,101

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) segment	Sep. 30, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment							2
Revenue	$ 872			$ 1,185			$ 2,866	$ 4,050
Cost of revenues	648			841			2,244	2,800
Gross profit	$ 224			$ 344			$ 622	$ 1,250
Gross profit %	26%			29%			22%	31%
Total operating expenses	$ 1,149			$ 7,504			$ 3,841	$ 21,965
Loss from operations	(925)			(7,160)			(3,219)	(20,715)
Interest and other (income) expense, net	(30)			(5)			(94)	1
Loss before income taxes	(895)			(7,155)			(3,125)	(20,716)
Income tax (benefit) expense	0			(3)			38	8
Net loss	(895)	$ (1,049)	$ (1,219)	(7,152)	$ (9,033)	$ (4,539)	(3,163)	(20,724)
Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	151			6,425			64	18,011
Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	998			1,079			3,777	3,954
Unallocated operating expenses
Segment Reporting Information [Line Items]
Revenue	0			0			0	0
Cost of revenues	0			0			0	0
Gross profit	0			0			0	0
Total operating expenses	998			1,079			3,777	3,954
Loss from operations	(998)			(1,079)			(3,777)	(3,954)
Interest and other (income) expense, net	0			0			0	0
Loss before income taxes	(998)			(1,079)			(3,777)	(3,954)
Income tax (benefit) expense	0			0			0	0
Net loss	(998)			(1,079)			(3,777)	(3,954)
Unallocated operating expenses | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0			0			0	0
Unallocated operating expenses | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	998			1,079			3,777	3,954
Managed Services | Operating Segments
Segment Reporting Information [Line Items]
Revenue	603			797			1,933	2,573
Cost of revenues	398			552			1,288	1,722
Gross profit	$ 205			$ 245			$ 645	$ 851
Gross profit %	34%			31%			33%	33%
Total operating expenses	$ 0			$ 0			$ 3	$ 57
Loss from operations	205			245			642	794
Interest and other (income) expense, net	(35)			(1)			(69)	7
Loss before income taxes	240			244			711	787
Income tax (benefit) expense	0			0			7	8
Net loss	240			244			704	779
Managed Services | Operating Segments | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0			0			3	57
Managed Services | Operating Segments | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0			0			0	0
Collaboration Products | Operating Segments
Segment Reporting Information [Line Items]
Revenue	269			388			933	1,477
Cost of revenues	250			289			956	1,078
Gross profit	$ 19			$ 99			$ (23)	$ 399
Gross profit %	7%			26%			(2.00%)	27%
Total operating expenses	$ 151			$ 6,425			$ 61	$ 17,954
Loss from operations	(132)			(6,326)			(84)	(17,555)
Interest and other (income) expense, net	5			(6)			(25)	(6)
Loss before income taxes	(137)			(6,320)			(59)	(17,549)
Income tax (benefit) expense	0			(3)			31	0
Net loss	(137)			(6,317)			(90)	(17,549)
Collaboration Products | Operating Segments | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	151			6,425			61	17,954
Collaboration Products | Operating Segments | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	$ 0			$ 0			$ 0	$ 0

Segment Reporting - Disaggregat

Segment Reporting - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 872	$ 1,185	$ 2,866	$ 4,050
Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 872	$ 1,185	$ 2,866	$ 4,050
Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	100%	100%	100%	100%
Managed Services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 603	$ 797	$ 1,933	$ 2,573
Managed Services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	69%	67%	67%	64%
Managed Services | Video collaboration services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 38	$ 69	$ 148	$ 264
Managed Services | Video collaboration services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	4%	6%	5%	7%
Managed Services | Network services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 557	$ 716	$ 1,758	$ 2,260
Managed Services | Network services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	64%	60%	61%	56%
Managed Services | Professional and other services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 8	$ 12	$ 27	$ 49
Managed Services | Professional and other services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	1%	1%	1%	1%
Collaboration Products | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 269	$ 388	$ 933	$ 1,477
Collaboration Products | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	31%	33%	33%	36%
Collaboration Products | Video collaboration services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 268	$ 385	$ 932	$ 1,467
Collaboration Products | Video collaboration services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	31%	33%	33%	36%
Collaboration Products | Professional services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue			$ 1	$ 0
Collaboration Products | Professional services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)			0%	0%
Collaboration Products | Licensing | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 3	$ 0	$ 10
Collaboration Products | Licensing | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (in percent)	0%	0%	0%	0%
Domestic
Disaggregation of Revenue [Line Items]
Revenue	$ 356	$ 575	$ 1,356	$ 2,120
Foreign
Disaggregation of Revenue [Line Items]
Revenue	$ 516	$ 610	$ 1,510	$ 1,930

Segment Reporting - Concentrati

Segment Reporting - Concentration Percentage (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Concentration Risk [Line Items]
Revenue	$ 872	$ 1,185	$ 2,866	$ 4,050
Revenue | Geographic Concentration Risk | UNITED KINGDOM
Concentration Risk [Line Items]
Concentration risk, percentage (in percent)	11%
Revenue | Geographic Concentration Risk | SINGAPORE
Concentration Risk [Line Items]
Concentration risk, percentage (in percent)		10%
Customer A | Managed Services | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage (in percent)	60%	53%	56%	48%
Customer A | Managed Services | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage (in percent)			0%	52%
Customer B | Collaboration Products | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage (in percent)			38%	0%
Customer C | Collaboration Products | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage (in percent)			0%	12%
Customer D | Collaboration Products | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage (in percent)			12%	0%

Subsequent Events (Details)

Subsequent Events (Details) - shares	1 Months Ended
	Nov. 08, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Common stock, shares issued (in shares)		4,294,455		2,070,861
Common stock, shares outstanding (in shares)		4,286,902		2,063,308
Preferred stock, shares issued (in shares)		5,146		0
Preferred stock, shares outstanding (in shares)		5,146		0
Series F Preferred Stock
Subsequent Event [Line Items]
Preferred stock, shares outstanding (in shares)		5,146	6,375
Subsequent Event
Subsequent Event [Line Items]
Common stock, shares issued (in shares)	14,955,475
Common stock, shares outstanding (in shares)	14,947,922
Conversions of Series F Preferred Stock (in shares)	10,661,020
Subsequent Event | Series F Preferred Stock
Subsequent Event [Line Items]
Preferred stock, shares issued (in shares)	2,278
Preferred stock, shares outstanding (in shares)	2,278